Anika Therapeutics Inc.

Historical 13F Holders

Symbol
ANIK
CUSIP
035255108
All holders as of
Q1 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q1 111 12.7 M $191 M
2024 Q4 114 12.6 M $207 M
2024 Q3 126 13.1 M $324 M
2024 Q2 121 13.8 M $349 M
2024 Q1 129 14.8 M $377 M
2023 Q4 124 13.8 M $314 M
2023 Q3 120 13.0 M $242 M
2023 Q2 121 13.1 M $340 M
2023 Q1 128 13.1 M $377 M
2022 Q4 131 14.0 M $415 M
2022 Q3 128 14.1 M $335 M
2022 Q2 129 13.5 M $302 M
2022 Q1 122 13.6 M $342 M
2021 Q4 130 13.5 M $485 M
2021 Q3 136 13.2 M $560 M
2021 Q2 141 13.1 M $569 M
2021 Q1 156 13.3 M $543 M
2020 Q4 177 14.4 M $654 M
2020 Q3 167 13.6 M $482 M
2020 Q2 171 13.9 M $525 M
2020 Q1 176 13.2 M $381 M
2019 Q4 206 13.9 M $720 M
2019 Q3 208 13.9 M $761 M
2019 Q2 183 14.2 M $575 M
2019 Q1 170 13.4 M $405 M
2018 Q4 168 12.9 M $435 M
2018 Q3 173 13.4 M $566 M
2018 Q2 180 14.2 M $455 M
2018 Q1 175 12.5 M $623 M
2017 Q4 176 12.4 M $670 M
2017 Q3 172 12.4 M $726 M
2017 Q2 165 12.4 M $613 M
2017 Q1 163 11.9 M $519 M
2016 Q4 167 11.5 M $562 M
2016 Q3 168 11.1 M $530 M
2016 Q2 166 11.5 M $619 M
2016 Q1 168 12.9 M $576 M
2015 Q4 159 13.2 M $475 M
2015 Q3 141 12.5 M $402 M
2015 Q2 140 12.1 M $401 M
2015 Q1 164 12.3 M $505 M
2014 Q4 164 11.9 M $483 M
2014 Q3 158 11.2 M $409 M
2014 Q2 168 10.2 M $473 M
2014 Q1 159 10.2 M $417 M